Spire Wealth Management Amphastar Pharmaceuticals, Inc. Transaction History
Spire Wealth Management
- $2.7 Billion
- Q2 2025
A detailed history of Spire Wealth Management transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 212 shares of AMPH stock, worth $4,922. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212
Previous 212
-0.0%
Holding current value
$4,922
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.1MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$138 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$62.4 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$47.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$37.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$36.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.14B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...